These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 30393970)
1. SUMO1 promotes the proliferation and invasion of non-small cell lung cancer cells by regulating NF-κB. Ke C; Zhu K; Sun Y; Ni Y; Zhang Z; Li X Thorac Cancer; 2019 Jan; 10(1):33-40. PubMed ID: 30393970 [TBL] [Abstract][Full Text] [Related]
2. CiRS-7 targeting miR-7 modulates the progression of non-small cell lung cancer in a manner dependent on NF-κB signalling. Su C; Han Y; Zhang H; Li Y; Yi L; Wang X; Zhou S; Yu D; Song X; Xiao N; Cao X; Liu Z J Cell Mol Med; 2018 Jun; 22(6):3097-3107. PubMed ID: 29532994 [TBL] [Abstract][Full Text] [Related]
3. Id-1 promotes migration and invasion of non-small cell lung cancer cells through activating NF-κB signaling pathway. Li J; Li Y; Wang B; Ma Y; Chen P J Biomed Sci; 2017 Dec; 24(1):95. PubMed ID: 29233161 [TBL] [Abstract][Full Text] [Related]
4. Foxp3 downregulation in NSCLC mediates epithelial-mesenchymal transition via NF-κB signaling. Wang X; Liu Y; Dai L; Liu Q; Jia L; Wang H; An L; Jing X; Liu M; Li P; Cheng Z Oncol Rep; 2016 Oct; 36(4):2282-8. PubMed ID: 27574108 [TBL] [Abstract][Full Text] [Related]
5. Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling. Wang W; Liu F; Wang C; Wang C; Tang Y; Jiang Z Med Sci Monit; 2018 Mar; 24():1282-1294. PubMed ID: 29500337 [TBL] [Abstract][Full Text] [Related]
6. Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathway. Tang ZP; Dong QZ; Cui QZ; Papavassiliou P; Wang ED; Wang EH PLoS One; 2013; 8(6):e63676. PubMed ID: 23776433 [TBL] [Abstract][Full Text] [Related]
7. IL-6 promotes metastasis of non-small-cell lung cancer by up-regulating TIM-4 via NF-κB. Liu W; Wang H; Bai F; Ding L; Huang Y; Lu C; Chen S; Li C; Yue X; Liang X; Ma C; Xu L; Gao L Cell Prolif; 2020 Mar; 53(3):e12776. PubMed ID: 32020709 [TBL] [Abstract][Full Text] [Related]
8. Hyperforin Suppresses Tumor Growth and NF-κB-mediated Anti-apoptotic and Invasive Potential of Non-small Cell Lung Cancer. Chen WT; Chen YK; Lin SS; Hsu FT Anticancer Res; 2018 Apr; 38(4):2161-2167. PubMed ID: 29599335 [TBL] [Abstract][Full Text] [Related]
9. S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide. Stewart RL; Carpenter BL; West DS; Knifley T; Liu L; Wang C; Weiss HL; Gal TS; Durbin EB; Arnold SM; O'Connor KL; Chen M Oncotarget; 2016 Jun; 7(23):34630-42. PubMed ID: 27127879 [TBL] [Abstract][Full Text] [Related]
10. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway. Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534 [TBL] [Abstract][Full Text] [Related]
11. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression. Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326 [TBL] [Abstract][Full Text] [Related]
12. Tripartite motif-containing 37 (TRIM37) promotes the aggressiveness of non-small-cell lung cancer cells by activating the NF-κB pathway. Li Y; Deng L; Zhao X; Li B; Ren D; Yu L; Pan H; Gong Q; Song L; Zhou X; Dai T J Pathol; 2018 Nov; 246(3):366-378. PubMed ID: 30043491 [TBL] [Abstract][Full Text] [Related]
13. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling. Huang RS; Zheng YL; Zhao J; Chun X Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202 [TBL] [Abstract][Full Text] [Related]
14. Overexpressed D2 Dopamine Receptor Inhibits Non-Small Cell Lung Cancer Progression through Inhibiting NF-κB Signaling Pathway. Wu XY; Zhang CX; Deng LC; Xiao J; Yuan X; Zhang B; Hou ZB; Sheng ZH; Sun L; Jiang QC; Zhao W Cell Physiol Biochem; 2018; 48(6):2258-2272. PubMed ID: 30114693 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells. Yao F; Liu H; Li Z; Zhong C; Fang W Tumour Biol; 2015 Mar; 36(3):2049-57. PubMed ID: 25391426 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of RPA2 promotes NF-κB activation in breast cancer by relieving the antagonistic function of menin on NF-κB-regulated transcription. Chen CC; Juan CW; Chen KY; Chang YC; Lee JC; Chang MC Carcinogenesis; 2017 Feb; 38(2):196-206. PubMed ID: 28007956 [TBL] [Abstract][Full Text] [Related]
17. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance. Shen L; Yang M; Lin Q; Zhang Z; Zhu B; Miao C Oncol Rep; 2016 Aug; 36(2):877-85. PubMed ID: 27373316 [TBL] [Abstract][Full Text] [Related]
18. High CXC Chemokine Ligand 16 (CXCL16) Expression Promotes Proliferation and Metastasis of Lung Cancer via Regulating the NF-κB Pathway. Liang K; Liu Y; Eer D; Liu J; Yang F; Hu K Med Sci Monit; 2018 Jan; 24():405-411. PubMed ID: 29353287 [TBL] [Abstract][Full Text] [Related]
19. PDLIM2 acts as a cancer suppressor gene in non-small cell lung cancer via the down regulation of NF-κB signaling. Shi H; Ji Y; Li W; Zhong Y; Ming Z Mol Cell Probes; 2020 Oct; 53():101628. PubMed ID: 32621848 [TBL] [Abstract][Full Text] [Related]